A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes

Clinical trial NCT05063253 · UNKNOWN

Trial details

NCT number: NCT05063253
Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2021-10-01
Primary completion: 2024-03-01
Enrollment: 208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.